|
FAM83G expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.527600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.938600E-01 |
| Normal-vs-Stage2 |
8.309000E-01 |
| Normal-vs-Stage3 |
4.721600E-01 |
| Normal-vs-Stage4 |
3.639600E-01 |
| Stage1-vs-Stage2 |
7.707400E-01 |
| Stage1-vs-Stage3 |
2.474000E-01 |
| Stage1-vs-Stage4 |
2.344800E-01 |
| Stage2-vs-Stage3 |
6.063600E-01 |
| Stage2-vs-Stage4 |
4.823000E-01 |
| Stage3-vs-Stage4 |
7.484000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.858000E-01 |
| Normal-vs-AfricanAmerican |
9.450600E-01 |
| Normal-vs-Asian |
8.798000E-01 |
| Caucasian-vs-AfricanAmerican |
7.414000E-01 |
| Caucasian-vs-Asian |
5.937600E-01 |
| AfricanAmerican-vs-Asian |
9.499600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.611600E-01 |
| Normal-vs-Female |
9.865800E-01 |
| Male-vs-Female |
3.979700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.971600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.032600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.814610E-01 |
| Normal-vs-Age(81-100Yrs) |
9.551000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.860100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.382300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.551000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.674010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.061000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.739200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.523600E-02 |
| Classical-VS-Follicular |
3.496300E-03 |
| Classical-VS-Other |
1.954850E-01 |
| Classical-VS-Normal |
6.790600E-01 |
| Tall-VS-Follicular |
4.739400E-01 |
| Tall-VS-Other |
4.008000E-01 |
| Tall-VS-Normal |
3.869200E-01 |
| Follicular-VS-Other |
7.531600E-01 |
| Follicular-VS-Normal |
1.269620E-01 |
| Other-VS-Normal |
3.672400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.504400E-01 |
| Normal-vs-N1 |
5.407800E-01 |
| N0-vs-N1 |
9.961800E-01 |
|
|
